Evidence-based cross validation for acoustic power transmission for a novel treatment system.

导出 LinkOut

翻译打印收藏纠错

作者： Senay,Mihcin ^[1] ; Jan,Strehlow ^[2] ; Daniel,Demedts ^[2] ; Michael,Schwenke ^[2] ; Yoav,Levy ^[3] ; Andreas,Melzer ^[1]

作者单位： a School of Medicine, University of Dundee , Dundee , UK. ^[1] b Fraunhofer MEVIS , Bremen , Germany. ^[2] c InSightec , Tirat Carmel , Israel. ^[3]

关键词 Acoustic power measurement for reliability Bland-Altman cross-validation legislation pre-clinical MRgFUS quality assurance two-sample t-test

主题词声学(Acoustics);高强聚焦超声消融(High-Intensity Focused Ultrasound Ablation);人类(Humans);肝肿瘤(Liver Neoplasms);磁共振成像(Magnetic Resonance Imaging);结果可重复性(Reproducibility of Results);软件(Software)

DOI 10.1080/13645706.2016.1273836

PMID 28084136

发布时间 2019-12-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览6

Minimally invasive therapy & allied technologies

2017年26卷3期

151-161页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Evidence-based cross validation for acoustic power transmission for a novel treatment system.

Minimally invasive therapy & allied technologies

相似文献

Minimally invasive therapy & allied technologies

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Evidence-based cross validation for acoustic power transmission for a novel treatment system.

Minimally invasive therapy & allied technologies

相似文献

Minimally invasive therapy & allied technologies

相关期刊

检索历史清除